Pakawadee PONGKET, Lawan LARSUPROM, Amornrate SASTRAVAHA, Sirin THEERAWATANASIRIKUL

Atopic dog skin shows decrease of claudin-1 but increase of atopic signature cytokines

Canine atopic dermatitis is a common allergic skin disease in dogs caused by defects in immunological and epidermal barriers. Claudin-1, a protein present in tight junctions, is associated with many skin conditions. Our aim was to investigate expression levels of claudin-1 and atopic signature cytokines in atopic and normal dog skins. The affected skin showed significantly decreased intensity and epidermal distribution of claudin-1 compared to the normal control skin (P< 0.05). The CD3+/CD4+ and CD3+/CD8+ T cell subsets, eosinophils, and neutrophils infiltrated the affected epidermis and dermis. The CD3+/CD4+ T cell subsets in lesional skin were significantly higher than CD3+/CD8+ T cell subsets. CLDN-1 mRNA expression was markedly downregulated in the lesional skin, while IL-17A was upregulated in both lesional and nonlesional skin. IL-4 and IL-31 mRNA was upregulated in the lesional skin, andTNF-α mRNA was significantly upregulated in the nonlesional skin (P < 0.01 and P < 0.05, respectively). Correlation-based hierarchical clustering showed that CLDN-1 expression was closely clustered with IL-31 but loosely clustered with L-4, IL-10, IL-13, and IL-17A.Wesuggest that the alteration of claudin-1 in atopic dogs may disrupt the skin barrier and allow an influx of allergens, inciting inflammatory cytokine responses.

PDF

___

1. Olivry T, Mueller R, Nuttall T, Favrot C, Prélaud P. Determination of CADESI-03 thresholds for increasing severity levels of canine atopic dermatitis. Vet Dermatol 2008; 19: 115119.
2. Favrot C, Steffan J, Seewald W, Picco F. A prospective study on the clinical features of chronic canine atopic dermatitis and its diagnosis. Vet Dermatol 2010; 21: 2331.
3. Suriyaphol G, Theerawatanasirikul S, Chansiripornchai P. Association of gap junction beta 2 and transglutaminase 1 gene expression with canine atopic dermatitis. Thai J Vet Med 2014; 44: 279285.
4. Theerawatanasirikul S, Sailasuta A, Thanawongnuwech R, Nakbed T, Charngkaew K, Gunnaporn S. Differential expression patterns of proteins involved in epidermal proliferation and differentiation in canine atopic dermatitis. Thai J Vet Med 2012; 42: 287296.
5. Jensen JM, Fölster-Holst R, Baranowsky A, Schunck M, Winoto-Morbach S, Neumann C, Schütze S, Proksch E. Impaired sphingomyelinase activity and epidermal differentiation in atopic dermatitis. J Invest Dermatol 2004; 122: 14231431.
6. Brandner JM. Tight junctions and tight junction proteins in mammalian epidermis. Eur J Pharm Biopharm 2009; 72: 289294.
7. Kirschner N, Houdek P, Fromm M, Moll I, Brandner JM. Tight junctions form a barrier in human epidermis. Eur J Cell Bio 2010; 89: 839842.
8. Furuse M, Hata M, Furuse K, Yoshida Y, Haratake A, Sugitani Y, Noda T, Kubo A, Tsukita S. Claudin-based tight junctions are crucial for the mammalian epidermal barrier: a lesson from claudin-1-deficient mice. J Cell Sci 2002; 156: 10991111.
9. Kirschner N, Poetzl C, von den Driesch P, Wladykowski E, Moll I, Behne MJ, Brandner JM. Alteration of tight junction proteins is an early event in psoriasis: putative involvement of proinflammatory cytokines. Am J Pathol 2009; 175: 10951106.
10. Sugawara T, Iwamoto N, Akashi M, Kojima T, Hisatsune J, Sugai M, Furuse M. Tight junction dysfunction in the stratum granulosum leads to aberrant stratum corneum barrier function in claudin-1-deficient mice. J Dermatol Sci 2013; 70: 1218.
11. Roussel JJ, Knol C, Bourdeau PJ, Bruet V. Optimization of an immunohistochemical method to assess distribution of tight junction proteins in canine epidermis and adnexae. J Comp Pathol 2014; 150: 3546.
12. Bizikova P, Linder KE, Olivry T. Immunomapping of desmosomal and nondesmosomal adhesion molecules in healthy canine footpad, haired skin and buccal mucosal epithelia: comparison with canine pemphigus foliaceus serum immunoglobulin G staining patterns. Vet Dermatol 2011, 22: 132142.
13. Roussel AJ, Bruet V, Marsella R, Knol AC, Bourdeau PJ. Tight junction proteins in the canine epidermis: a pilot study on their distribution in normal and in high IgE-producing canines. Can J Vet Res 2015; 79: 4651.
14. De Benedetto A, Rafaels NM, McGirt LY, Ivanov AI, Georas SN, Cheadle C, Berger AE, Zhang K, Vidyasagar S, Yoshida T et al. Tight junction defects in patients with atopic dermatitis. J Allergy Clin Immunol 2011; 127: 773786.
15. Wan H, Winton HL, Soeller C, Tovey ER, Gruenert DC, Thompson PJ, Stewart GA, Taylor GW, Garrod DR, Cannell MB et al. Der p 1 facilitates transepithelial allergen delivery by disruption of tight junctions. J Clin Invest 1999; 104:123133.
16. De Benedetto A, Slifka MK, Rafaels NM, Kuo IH, Georas SN, Boguniewicz M, Hata T, Schneider LC, Hanifin JM, Gallo RL et al. Reductions in claudin-1 may enhance susceptibility to herpes simplex virus 1 infections in atopic dermatitis. J Allergy Clin Immunol 2011; 128: 242246.
17. Plant JD, Gortel K, Kovalik M, Polissar NL, Neradilek MB. Development and validation of the Canine Atopic Dermatitis Lesion Index, a scale for the rapid scoring of lesion severity in canine atopic dermatitis. Vet Dermatol 2012; 23: 515e103.
18. Santoro D, Bunick D, Graves TK, Segre M. Evaluation of canine antimicrobial peptides in infected and noninfected chronic atopic dermatitis. Vet Dermatol 2013; 24: 3947.
19. Pfaffl MW, Horgan GW, Dempfle L. Relative expression software tool (REST) for group-wise comparison and statistical analysis of relative expression results in real-time PCR. Nucleic Acids Res 2002; 30: e36.
20. Saeed AI, Bhagabati NK, Braisted JC, Liang W, Sharov V, Howe EA, Li J, Thiagarajan M, White JA, Quackenbush J. TM4 microarray software suite. Meth Enzymol 2006; 411: 134193.
21. Samochocki Z, Alifier M, Bodera P, Jeziorkowska R, Rosiak E, Jurkiewicz B, Glińska O, Gliński W, Stankiewicz W. T-regulatory cells in severe atopic dermatitis: alterations related to cytokines and other lymphocyte subpopulations. Arch Dermatol Res 2012; 304: 795801.
22. McCandless EE, Rugg C, Fici GJ, Messamore JE, Aleo MM, Gonzales AJ. Allergen-induced production of IL-31 by canine Th2 cells and identification of immune, skin, and neuronal target cells. Vet Immunol Immunopathol 2014; 157: 4248.
23. Gutowska-Owsiak D, Schaupp AL, Salimi M, Selvakumar TA, McPherson T, Taylor S, Ogg GS. IL-17 downregulates filaggrin and affects keratinocyte expression of genes associated with cellular adhesion. Exp Dermatol 2012; 21: 104110.
24. Oyoshi MK, Murphy GF, Geha RS. Filaggrin-deficient mice exhibit Th17-dominated skin inflammation and permissiveness to epicutaneous sensitization with protein antigen. J Allergy Clin Immunol 2009; 124: 485493.
25. Griffin GK, Newton G, Tarrio ML, Bu D, Maganto-Garcia E, Azcutia V, Alcaide P, Grabie N, Luscinskas FW, Croce KJ et al. IL-17 and TNF-α sustain neutrophil recruitment during inflammation through synergistic effects on endothelial activation. J Immunol 2012; 188: 62876299.
26. Hennino A, Vocanson M, Toussaint Y, Rodet K, Benetière J, Schmitt AM, Aries MF, Bérard F, Rozières A, Nicolas JF. Skin-infiltrating CD8+ T cells initiate atopic dermatitis lesions. J Immunol 2007; 178: 55715577.
27. Nobbe S, Dziunycz P, Mühleisen B, Dillon SR, French LE, Hofbauer GFL. IL-31 expression by inflammatory cells is preferentially elevated in atopic dermatitis. Acta Derm Venereol 2012; 92: 2428.
28. Dillon SR, Sprecher C, Hammond A, Bilsborough J, Rosenfeld-Franklin J, Presnell SR, Haugen HS, Maurer M, Harder B, Johnston J et al. Interleukin 31, a cytokine produced by activated T cells, induces dermatitis in mice. Nat Immunol 2004; 5: 752760.
29. Gonzales AJ, Humphrey WR, Messamore JE, Fleck TJ, Fici GJ, Shelly J, Teel JF, Bammert GF, Dunham S, Fuller TE et al. Interleukin-31: its role in canine pruritus and naturally occurring canine atopic dermatitis. Vet Dermatol 2013; 24: 4853.